For someone weighing 100kg, this means you could expect to lose around 22kg with Mounjaro and 17kg with Wegovy 2.4 mg when combined with comprehensive support, both above the clinically significant threshold of 10%
Observational studies in humans report lower circulating spexin levels in obesity and metabolic syndrome, supporting its role as an endogenous metabolic regulator rather than a stress-induced peptide ( More recent analyses suggest that spexins metabolic actions may be dissociable from its nociceptive or affective effects through receptor subtype selectivity and dosing strategies ( 4.3 Meteorin-like protein (METRNL) and exercise-induced endocrinology Meteorin-like protein (METRNL) occupies a distinct conceptual niche within metabolic peptide biology
in misuse scenarios, cardiomegaly has been reported
Clinical trials have shown this dose produces significant weight loss over 56 weeks, with many participants achieving 510 % of baseline body weight reduction
So be prepared to fall in love, which could be costly
More about Zepbound (tirzepatide) Check interactions Compare alternatives Pricing & coupons Reviews (726) Drug images Latest FDA alerts (3) Side effects Dosage information During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Professional resources Other brands Related treatment guides Copyright 2023, 2026, Eli Lilly and Company